AC Immune (ACIU) Other Operating Expenses (2015 - 2026)

AC Immune (ACIU) has 12 years of Other Operating Expenses data on file, last reported at $14047.1 in Q1 2026.

• Quarterly Other Operating Expenses rose 1362.94% year-over-year to $14047.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139203.4 (up 69.48% YoY) and the FY2025 annual result came in at $113376.1, down 30.06% from the prior year.
• Other Operating Expenses fell to $14047.1 in Q1 2026 per ACIU's latest filing, from $91335.4 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $497009.0 in Q1 2022 and bottomed at -$1112.3 in Q1 2025.
• The 5-year median for Other Operating Expenses is $153131.0 (2025), against an average of $209386.3.
• The widest annual swing landed in 2025, when Other Operating Expenses plunged 101.43%; it then jumped 1362.94% in 2026.
• Tracing ACIU's Other Operating Expenses over 5 years: stood at $414170.7 in 2022, then slipped by 3.37% to $400210.8 in 2023, then slumped by 96.01% to $15981.3 in 2024, then surged by 471.51% to $91335.4 in 2025, then sank by 84.62% to $14047.1 in 2026.
• Per Business Quant, the three latest ACIU Other Operating Expenses figures stand at $14047.1 (Q1 2026), $91335.4 (Q4 2025), and $33820.9 (Q2 2025).

Peer Comparison